Hexagon Nutrition IPO opens June 5–9, 2026 on BSE & NSE Mainboard at ₹42–₹45. Issue size ₹138.87 crore. Founded 1993, exports to 75+ countries. PAT doubled to ₹24.38 crore in FY25. Minimum investment just ₹14,985 (1 lot). Allotment June 10, listing June 12. Complete review inside.
Hexagon Nutrition IPO 2026 — Complete Review, Price Band ₹45, GMP & Should You Apply?
Hexagon Nutrition Limited, one of India's leading research-driven nutrition companies founded in 1993, is opening its Mainboard IPO on June 5, 2026. With an issue size of ₹138.87 crore and listing on both BSE and NSE, this is the only mainboard IPO opening this week. Here is a complete, data-backed review.
---
## Hexagon Nutrition IPO — Key Details
| IPO Detail | Information |
|---|---|
| IPO Open Date | June 5, 2026 (Thursday) |
| IPO Close Date | June 9, 2026 (Monday) |
| Price Band | ₹42 – ₹45 per share |
| Face Value | ₹1 per share |
| Lot Size | 333 shares |
| Min. Investment (Retail — 1 lot) | ₹14,985 |
| Max. Investment (Retail — 13 lots) | ₹1,94,805 |
| Min. Investment (sNII — 14 lots) | ₹2,09,790 |
| Min. Investment (bNII — 67 lots) | ₹10,03,995 |
| Issue Size | ₹138.87 crore |
| Fresh Issue | ₹27.29 crore |
| Offer for Sale (OFS) | 3,08,59,704 shares |
| Retail Quota | 35% |
| QIB Quota | 50% |
| HNI Quota | 15% |
| Listing Exchange | BSE & NSE (Mainboard) |
| Allotment Date | June 10, 2026 |
| Listing Date | June 12, 2026 |
| Registrar | KFin Technologies Ltd. |
| Lead Manager | Cumulative Capital Pvt. Ltd. |
---
## Hexagon Nutrition IPO GMP Today — June 1, 2026
The Hexagon Nutrition IPO GMP (Grey Market Premium) today is **Flat / ₹0**, indicating the grey market has not yet formed strong momentum ahead of the June 5 opening. This is typical for mainboard IPOs at this stage. Investors should track GMP movement as the IPO approaches opening.
> **Note:** A flat GMP does not mean poor fundamentals. Hexagon Nutrition has strong financials and a well-established brand portfolio. GMP often picks up closer to listing.
---
## About Hexagon Nutrition Limited
Incorporated in 1993 by the late Shri Vinod D. Shah and currently promoted by the Shah family, Hexagon Nutrition is a research-oriented, B2B + B2C nutrition company with manufacturing units in:
- **Maharashtra**
- **Tamil Nadu**
- **Uzbekistan** (international presence)
**Core business segments:**
- Micronutrient premixes
- Clinical and therapeutic nutrition
- Ready-to-use therapeutic foods (RUTF)
- Food fortification solutions
- Preventive healthcare and wellness products
**Well-known brands:** Pentasure, Obesigo, Pediagold, Nutrone
**Export presence:** Products exported to 75+ countries across Asia, Africa, Europe, and South America as of FY2025.
**Employees:** 527 permanent staff (as of March 31, 2026)
---
## Hexagon Nutrition Financial Performance
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue from Operations | — | ₹304.62 crore | ₹331.29 crore |
| Profit After Tax (PAT) | — | ₹12.21 crore | ₹24.38 crore |
| PAT Growth (YoY) | — | — | +99.67% (~2x) |
Revenue grew 8.7% in FY2025 while PAT nearly doubled — a strong profitability improvement signal. The company has shown a consistent upward trend in PAT and PAT margin over the past 3 years.
**IPO proceeds utilisation (Fresh Issue of ₹27.29 crore):**
- General corporate purposes and working capital
Note: The majority of the issue is OFS — meaning selling shareholders will receive proceeds, not the company directly.
---
## Hexagon Nutrition IPO Valuation
At the upper price band of ₹45, the issue appears **fully priced** based on peer comparison. The EPS is relatively modest compared to listed nutrition sector peers. However, the company's niche positioning in clinical nutrition, food fortification, and global exports supports a premium over pure domestic FMCG peers.
---
## Strengths & Risks
### ✅ Strengths
- 30+ year track record in clinical and micronutrient nutrition
- Export to 75+ countries — strong global footprint
- PAT doubled in FY2025 — profitability acceleration
- Well-known B2C brands (Pentasure, Pediagold, Obesigo)
- Research-driven product development — differentiated moat
### ⚠️ Risks
- Largely OFS issue — fresh capital infusion minimal (₹27.29 crore only)
- Relatively modest EPS compared to peers
- Revenue growth of 8.7% in FY2025 is moderate
- Promoter stake drops from 89.41% to 64.29% post IPO
---
## How to Apply for Hexagon Nutrition IPO
1. Open your broker app (Zerodha, Upstox, Angel One, Groww, ICICI Direct, etc.)
2. Navigate to the **IPO** section → search "Hexagon Nutrition"
3. Select 1 lot minimum (333 shares = ₹14,985 at ₹45)
4. Enter UPI ID and submit bid
5. Approve mandate in your UPI app before deadline
6. Check allotment on June 10, 2026
---
## Should You Apply?
Hexagon Nutrition is a well-established, fundamentally sound company with PAT doubling in FY2025 and a strong global export business. The low lot size (₹14,985) makes this highly accessible for retail investors. The flat GMP is a neutral signal — not a red flag.
**Verdict:** Apply for **long-term** investment. The nutrition and clinical healthcare market in India is structurally growing. Short-term listing gain is uncertain given flat GMP.
---
> **Disclaimer:** This article is for informational and educational purposes only and does not constitute investment advice. Consult a SEBI-registered investment advisor before applying.
